Holger Wesche - Jul 1, 2021 Form 4 Insider Report for Harpoon Therapeutics, Inc. (HARP)

Role
Chief Scientific Officer
Signature
/s/ Holger Wesche by Christopher Whitmore, Attorney-in-Fact
Stock symbol
HARP
Transactions as of
Jul 1, 2021
Transactions value $
-$134,000
Form type
4
Date filed
7/6/2021, 06:01 PM
Next filing
Nov 15, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HARP Common Stock Options Exercise $6K +10K +18.92% $0.60 62.9K Jul 1, 2021 Direct
transaction HARP Common Stock Sale -$140K -10K -15.91% $14.00* 52.9K Jul 1, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HARP Employee Stock Option (right to buy) Options Exercise $0 -10K -32.26% $0.00 21K Jul 1, 2021 Common Stock 10K $0.60 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F2 The shares subject to the option are fully vested and exercisable.